{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:50:16Z","timestamp":1791899416367,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Project of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972553"],"award-info":[{"award-number":["81972553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Natural Science Foundation of Hebei Province","award":["H2022206376"],"award-info":[{"award-number":["H2022206376"]}]},{"name":"Special Project of Clinical Medical Research Center of Department of Science and Technology of Hebei Province","award":["20577716D"],"award-info":[{"award-number":["20577716D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Laryngeal squamous cell carcinoma (LSCC) is a common malignancy of the head and neck. Recently, circular RNA (circRNA) has been studied extensively in multisystem diseases. However, there are few research on biological functions and molecular mechanisms of circRNAs in LSCC. CircRNA array was used to detect the differentially expressed circRNAs. Kaplan\u2013Meier and cox regression analysis were used to identify survival based on circMMP9. The qRT-PCR, RNase R treatment, sanger sequencing and in situ hybridization were used to verify circMMP9 expression, characteristics and localization in LSCC tissues and cells. Functionally, colony formation, MTS, transwell and in vivo assays were proceeded to detect the biological function of circMMP9 in LSCC progression. The RNA-seq was conducted to identify the molecular targets of circMMP9. Mechanically, MeRIP, RNA Immunoprecipitation (RIP), RNA pulldown, Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were carried on to verify the regulatory mechanism of circMMP9. CircMMP9 was discovered upregulated in LSCC tissues and cells, and high level of circMMP9 was associated with poor prognosis, low degree of pathological grading, high TNM stage and lymph node metastasis of LSCC. CircMMP9 knockdown prevented LSCC progression both in vitro and in vivo, whereas, circMMP9 overexpression had the opposite effect. CircMMP9 was stabilized by IGF2BP2 in m6A-dependent manner. TRIM59 was identified as downstream target of circMMP9. CircMMP9 recruited ETS1 to stimulate TRIM59 transcription. Moreover, TRIM59 accelerated LSCC progression via activating the PI3K\/AKT signal pathway. Our findings offered a unique regulatory mechanism for circMMP9 in LSCC, as well as a novel proof that circMMP9 may be utilize as a diagnostic marker and therapeutic target for LSCC patients.<\/jats:p>","DOI":"10.1038\/s41598-024-53422-4","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T09:02:15Z","timestamp":1707210135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Jinling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"53422_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L. et al. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J, Clin."},{"key":"53422_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L. et al. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5\u201329 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"53422_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer, J. D. et al. The changing therapeutic landscape of head and neck cancer. Nat. Rev. Clin. Oncol. 16, 669\u2013683 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"53422_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3322\/caac.21630","volume":"70","author":"JW Carlisle","year":"2020","unstructured":"Carlisle, J. W. et al. An update on the immune landscape in lung and head and neck cancers. CA Cancer J. Clin. 70, 505\u2013517 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"53422_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. J. Nat. Rev. Dis. Primers 6, 92 (2020).","journal-title":"J. Nat. Rev. Dis. Primers"},{"key":"53422_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. J. Nat. 495, 333\u2013338 (2013).","journal-title":"J. Nat."},{"key":"53422_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10020-021-00359-3","volume":"27","author":"M Tao","year":"2021","unstructured":"Tao, M. et al. CircRNAs and their regulatory roles in cancers. J. Mol. Med. 27, 94 (2021).","journal-title":"J. Mol. Med."},{"key":"53422_CR8","doi-asserted-by":"publisher","first-page":"13757","DOI":"10.1038\/s41598-022-17450-2","volume":"12","author":"J Bu","year":"2022","unstructured":"Bu, J. et al. The circRNA circADAMTS6 promotes progression of ESCC and correlates with prognosis. J. Sci. Rep. 12, 13757 (2022).","journal-title":"J. Sci. Rep."},{"key":"53422_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-020-01298-z","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Circular RNAs in body fluids as cancer biomarkers: The new frontier of liquid biopsies. J. Mol. Cancer 20, 13 (2021).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR10","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s00432-019-03045-4","volume":"145","author":"C Li","year":"2019","unstructured":"Li, C. et al. Circular RNAs: Pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 145, 2875\u20132889 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"53422_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen, L. L. The biogenesis and emerging roles of circular RNAs. J. Nat. Rev. Mol. Cell Biol. 17, 205\u2013211 (2016).","journal-title":"J. Nat. Rev. Mol. Cell Biol."},{"key":"53422_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Exon-intron circular RNAs regulate transcription in the nucleus. J. Nat. Struct. Mol. Biol. 22, 256\u2013264 (2015).","journal-title":"J. Nat. Struct. Mol. Biol."},{"key":"53422_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"M Jie","year":"2020","unstructured":"Jie, M. et al. CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification. J. Mol. Cancer 19, 1\u20136 (2020).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-020-01246-x","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. CircRNA inhibits DNA damage repair by interacting with host gene. J. Mol. Cancer 19, 128 (2020).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri, I. et al. Role of RNA modifications in cancer. J. Nat. Rev. Cancer 20, 303\u2013322 (2020).","journal-title":"J. Nat. Rev. Cancer"},{"key":"53422_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Dynamic transcriptomic m(6)A decoration: Writers, erasers, readers and functions in RNA metabolism. J. Cell Res. 28, 616\u2013624 (2018).","journal-title":"J. Cell Res."},{"key":"53422_CR17","first-page":"1346","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye, M. et al. RNA modifications modulate gene expression during development. J. Sci. 361, 1346\u20131349 (2018).","journal-title":"J. Sci."},{"key":"53422_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-021-02212-1","volume":"41","author":"D Yu","year":"2022","unstructured":"Yu, D. et al. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J. Exp. Clin. Cancer Res. 41, 6 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"53422_CR19","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.7150\/thno.51342","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization. J. Theranostics 11, 4298\u20134315 (2021).","journal-title":"J. Theranostics"},{"key":"53422_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. N(6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating beta-catenin signaling. J. Mol. Cancer 19, 163 (2020).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-021-01415-6","volume":"20","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Crosstalk between N6-methyladenosine modification and circular RNAs: Current understanding and future directions. J. Mol. Cancer 20, 121 (2021).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR22","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist. Updates 65, 100886 (2022).","journal-title":"Drug Resist. Updates"},{"key":"53422_CR23","doi-asserted-by":"publisher","first-page":"e0257445","DOI":"10.1371\/journal.pone.0257445","volume":"16","author":"Z Jin","year":"2021","unstructured":"Jin, Z. et al. TRIM59: A potential diagnostic and prognostic biomarker in human tumors. PLoS One 16, e0257445 (2021).","journal-title":"PLoS One"},{"key":"53422_CR24","first-page":"e108","volume":"127","author":"D Han","year":"2020","unstructured":"Han, D. et al. The tumor-suppressive human circular RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, survivin, and SERCA2a. J. Circ. Res. 127, e108\u2013e125 (2020).","journal-title":"J. Circ. Res."},{"key":"53422_CR25","first-page":"eabc9546","volume":"370","author":"J Han","year":"2020","unstructured":"Han, J. et al. A ubiquitin ligase mediates target-directed microRNA decay independently of tailing and trimming. J. Sci. 370, eabc9546 (2020).","journal-title":"J. Sci."},{"key":"53422_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.colsurfb.2016.06.059","volume":"146","author":"V Vaghi","year":"2016","unstructured":"Vaghi, V. et al. Bio-functional surfaces for the immunocapture of AGO2-bound microRNAs. J. Colloids Surf. B Biointerfaces 146, 746\u2013753 (2016).","journal-title":"J. Colloids Surf. B Biointerfaces"},{"key":"53422_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4149\/neo_2022_220310N263","volume":"69","author":"C Yang","year":"2022","unstructured":"Yang, C. et al. The ETS1-LINC00278 negative feedback loop plays a role in COL4A1\/COL4A2 regulation in laryngeal squamous cell carcinoma. J. Neoplasma 69, 841\u2013858 (2022).","journal-title":"J. Neoplasma"},{"key":"53422_CR28","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.7150\/ijbs.28757","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. TRIM59 is a novel marker of poor prognosis and promotes malignant progression of ovarian cancer by Inducing annexin A2 expression. Int. J. Biol. Sci. 14, 2073\u20132082 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"53422_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-020-01688-7","volume":"39","author":"M Liang","year":"2020","unstructured":"Liang, M. et al. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression. J. Exp. Clin. Cancer Res. 39, 176 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"53422_CR30","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/jcb.29433","volume":"121","author":"R Li","year":"2020","unstructured":"Li, R. et al. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K\/AKT\/mTOR-glycolysis signaling axis. J. Cell. Biochem. 121, 1986\u20131997 (2020).","journal-title":"J. Cell. Biochem."},{"key":"53422_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou, W. Y. et al. Circular RNA: Metabolism, functions and interactions with proteins. J. Mol. Cancer 19, 172 (2020).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","volume":"76","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J. Hepatol. 76, 135\u2013147 (2022).","journal-title":"J. Hepatol."},{"key":"53422_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li, B. et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. J. Nat. Commun. 12, 295 (2021).","journal-title":"J. Nat. Commun."},{"key":"53422_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-018-0911-0","volume":"17","author":"R Wang","year":"2018","unstructured":"Wang, R. et al. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. J. Mol. Cancer 17, 166 (2018).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR35","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.2147\/CMAR.S226264","volume":"11","author":"G Pan","year":"2019","unstructured":"Pan, G. et al. Upregulation of circMMP9 promotes osteosarcoma progression via targeting miR-1265\/CHI3L1 axis. J. Cancer Manag. Res. 11, 9225\u20139231 (2019).","journal-title":"J. Cancer Manag. Res."},{"key":"53422_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-022-01521-z","volume":"21","author":"HN Fan","year":"2022","unstructured":"Fan, H. N. et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p\/AKT1S1 axis. J. Mol. Cancer. 21, 51 (2022).","journal-title":"J. Mol. Cancer."},{"key":"53422_CR37","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.3390\/cancers13225708","volume":"13","author":"T Ando","year":"2021","unstructured":"Ando, T. et al. Tumor suppressive circular RNA-102450: Development of a novel diagnostic procedure for lymph node metastasis from oral cancer. J. Cancers (Basel) 13, 5708 (2021).","journal-title":"J. Cancers (Basel)"},{"key":"53422_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41598-020-79321-y","volume":"11","author":"S Lv","year":"2021","unstructured":"Lv, S. et al. CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498\/NAP1L3 axis. J. Sci. Rep. 11, 386 (2021).","journal-title":"J. Sci. Rep."},{"key":"53422_CR39","doi-asserted-by":"publisher","first-page":"24357","DOI":"10.1038\/s41598-021-03662-5","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion. J. Sci. Rep. 11, 24357 (2021).","journal-title":"J. Sci. Rep."},{"key":"53422_CR40","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. J. Clin. Investig. 131, (2021).","DOI":"10.1172\/JCI148020"},{"key":"53422_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.immuni.2018.10.012","volume":"49","author":"CJ Kim","year":"2018","unstructured":"Kim, C. J. et al. The transcription factor Ets1 suppresses T follicular helper type 2 cell differentiation to halt the onset of systemic lupus erythematosus. J. Immunity. 49, 1034-1048 e8 (2018).","journal-title":"J. Immunity."},{"key":"53422_CR42","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-022-01285-0","volume":"23","author":"M Yan","year":"2022","unstructured":"Yan, M. et al. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts. J. Nat. Immunol. 23, 1330\u20131341 (2022).","journal-title":"J. Nat. Immunol."},{"key":"53422_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2015.09.010","volume":"35","author":"J Dittmer","year":"2015","unstructured":"Dittmer, J. The role of the transcription factor Ets1 in carcinoma. J. Semin. Cancer Biol. 35, 20\u201338 (2015).","journal-title":"J. Semin. Cancer Biol."},{"key":"53422_CR44","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1080\/15548627.2018.1491493","volume":"14","author":"T Han","year":"2018","unstructured":"Han, T. et al. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1. J. Autophagy 14, 2035\u20132048 (2018).","journal-title":"J. Autophagy"},{"key":"53422_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3892\/or.2017.5654","volume":"38","author":"Y Sun","year":"2017","unstructured":"Sun, Y. et al. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K\/AKT pathway. J. Oncol. Rep. 38, 43\u201352 (2017).","journal-title":"J. Oncol. Rep."},{"key":"53422_CR46","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/mc.22897","volume":"57","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway. J. Mol. Carcinog. 57, 1792\u20131802 (2018).","journal-title":"J. Mol. Carcinog."},{"key":"53422_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma, S. et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J. Hematol. Oncol. 12, 121 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"53422_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01470-z","volume":"21","author":"B Shi","year":"2022","unstructured":"Shi, B. et al. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. J. Mol. Cancer 21, 1\u201315 (2022).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR49","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng, H. et al. The mA reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. J. Cancer Cell. 40, 1566-1582.e10 (2022).","journal-title":"J. Cancer Cell."},{"key":"53422_CR50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi, H. et al. Where, when, and how: Context-dependent functions of RNA methylation writers, readers, and erasers. J. Mol. Cell 74, 640\u2013650 (2019).","journal-title":"J. Mol. Cell"},{"key":"53422_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang, X. et al. The role of m6A modification in the biological functions and diseases. J. Signal Transduct. Target Ther. 6, 74 (2021).","journal-title":"J. Signal Transduct. Target Ther."},{"key":"53422_CR52","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","volume":"10","author":"RX Chen","year":"2019","unstructured":"Chen, R. X. et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. J. Nat. Commun. 10, 4695 (2019).","journal-title":"J. Nat. Commun."},{"key":"53422_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. J. Mol. Cancer 20, 105 (2021).","journal-title":"J. Mol. Cancer"},{"key":"53422_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12929-019-0506-0","volume":"26","author":"W Meng","year":"2019","unstructured":"Meng, W. et al. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma. J. Biomed. Sci. 26, 13 (2019).","journal-title":"J. Biomed. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53422-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T10:06:19Z","timestamp":1707213979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53422-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53422"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53422-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3014"}}